These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The prevalence of melanocytic naevi among teenagers]. Csoma Z; Erdei Z; Bartusek D; Dósa-Rácz E; Dobozy A; Kemény L; Oláh J Orv Hetil; 2008 Nov; 149(46):2173-82. PubMed ID: 19004735 [TBL] [Abstract][Full Text] [Related]
26. Which pigmented moles should be removed in prepubertal-age children? A case for a conservative approach. Keipert JA Med J Aust; 1984 Oct; 141(8):518-20. PubMed ID: 6482800 [TBL] [Abstract][Full Text] [Related]
27. Non-random spatial association of melanoma and naevi--a morphometric analysis. Smolle J; Kaddu S; Kerl H Melanoma Res; 1999 Aug; 9(4):407-12. PubMed ID: 10504061 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Melanocytic Naevi in Children from Lleida, Catalonia, Spain: Protective Role of Sunscreen in the Development of Acquired Moles. Moreno S; Soria X; Martínez M; Martí RM; Casanova JM Acta Derm Venereol; 2016 May; 96(4):479-84. PubMed ID: 26551264 [TBL] [Abstract][Full Text] [Related]
30. Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study--the Italian multidisciplinary group on melanoma. Chiarugi A; Quaglino P; Crocetti E; Nardini P; De Giorgi V; Borgognoni L; Brandani P; Gerlini G; Manganoni AM; Bernengo MG; Pimpinelli N; Melanoma Res; 2015 Feb; 25(1):80-7. PubMed ID: 25171087 [TBL] [Abstract][Full Text] [Related]
31. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? Skender-Kalnenas TM; English DR; Heenan PJ J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345 [TBL] [Abstract][Full Text] [Related]
32. Freckles, moles, melanoma and the ozone layer: a tale of the relationship between humans and their environment. Marks R Med J Aust; 1989 Dec 4-18; 151(11-12):611-3. PubMed ID: 2593903 [No Abstract] [Full Text] [Related]
33. Frequency of moles as a key to melanoma incidence? Rampen FH; van der Meeren HL; Boezeman JB J Am Acad Dermatol; 1986 Dec; 15(6):1200-3. PubMed ID: 3492519 [TBL] [Abstract][Full Text] [Related]
34. The distribution of melanocytic naevi in melanoma patients and control subjects. Kelly JW; Holly EA; Shpall SN; Ahn DK Australas J Dermatol; 1989; 30(1):1-8. PubMed ID: 2486046 [TBL] [Abstract][Full Text] [Related]
35. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands. Zaal LH; Mooi WJ; Klip H; van der Horst CM Plast Reconstr Surg; 2005 Dec; 116(7):1902-9. PubMed ID: 16327602 [TBL] [Abstract][Full Text] [Related]
37. A retrospective study of melanocytic naevi at the National Skin Centre. Kwok YK; Giam YC; Tan SH; Sim CS Ann Acad Med Singap; 2001 Jan; 30(1):32-7. PubMed ID: 11242622 [TBL] [Abstract][Full Text] [Related]
38. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. Weinstock MA; Colditz GA; Willett WC; Stampfer MJ; Bronstein BR; Mihm MC; Speizer FE J Natl Cancer Inst; 1989 Jun; 81(12):948-52. PubMed ID: 2733040 [TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study. Yun SJ; Kwon OS; Han JH; Kweon SS; Lee MW; Lee DY; Kim MB; Kim YC; Yoon TY; Chung KY; Kim IH; Kim KH; Suh KS; Lee SJ; Seo YJ; Kim KH; Park HJ; Roh MR; Ahn KJ; Yoon TJ; Kim MH; Li KS; Park JS; Shin BS; Ko JY; Ahn HH; Kim HJ; Park SD; Jang SJ; Won YH Br J Dermatol; 2012 Jan; 166(1):115-23. PubMed ID: 21923752 [TBL] [Abstract][Full Text] [Related]
40. [Congenital naevi: should we remove them?]. Fraitag S Presse Med; 2013 Feb; 42(2):127-31. PubMed ID: 23253257 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]